XOSPATA (gilteritinib) Available at Biologics by McKesson
CARY, N.C., December 7, 2018 — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, […]
CARY, N.C., December 7, 2018 — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, […]
LAS COLINAS, TEXAS and SAN FRANCISCO, December 6, 2018—McKesson Corporation, which has been investing in technologies and services that create […]
ANAHEIM, Calif., December 3, 2018—McKesson will showcase its clinical expertise and comprehensive suite of technology solutions at the American Society […]
SAN FRANCISCO—November 1, 2018–McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided […]
PITTSBURGH, PA and LOUISVILLE, KY, Nov. 2, 2018—PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the […]
IRVING, TEXAS, November 27, 2018—McKesson, an industry leader in services and technologies that advance community-based healthcare, announced that Lynx®, its customizable, […]
IRVING, Texas, November 29, 2018— The McKesson RxO® team, a group of trusted advisors working to help hospital and health […]
THE WOODLANDS, TEXAS, November 30, 2018 — During the 60th American Society of Hematology (ASH) Annual Meeting and Exposition, principal […]
Move supports company’s multi-year strategic growth initiative.Company to move most San Francisco Bay Area jobs to Las Colinas and other […]
Move supports company’s multi-year strategic growth initiative.Company to move most San Francisco Bay Area jobs to Las Colinas and other […]